4016.SR
4016.SR
SA160G51UO10
Middle East Pharmaceutical Indu
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.21B EUR
2.12B EUR
1.95B EUR
2.22B EUR
Enterprise Value
2.28B EUR
2.21B EUR
2.01B EUR
2.25B EUR
Valuation Multiples
Trailing P/E
26.14x
19.52x
18.65x
28.66x
Forward P/E
12.4x
--
--
--
Price to Sales
4.32x
4.14x
3.95x
6.12x
Price to Book
4.97x
4.75x
4.67x
5.34x
EV/Revenue
4.46x
4.32x
4.08x
6.21x
EV/EBITDA
17.51x
15.39x
14.65x
22.19x
Price to FCF (P/FCF)
--
100.4x
58.09x
57.39x
EV/FCF
--
104.95x
60.02x
58.15x
FCF Yield
-1.04%
1%
1.72%
1.74%
ende